Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Lexeo Therapeutics Inc’s stock clocked out at $6.65, down -14.52% from its previous closing price of $7.78. In other words, the price has decreased by -$14.52 from its previous closing price. On the day, 0.78 million shares were traded. LXEO stock price reached its highest trading level at $7.95 during the session, while it also had its lowest trading level at $6.65.
Ratios:
To gain a deeper understanding of LXEO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.95 and its Current Ratio is at 5.95. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $28.
On June 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $22.
On November 28, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on November 28, 2023, with a $20 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 11 ’24 when Townsend Richard Nolan sold 2,500 shares for $7.82 per share. The transaction valued at 19,557 led to the insider holds 120,695 shares of the business.
Townsend Richard Nolan sold 5,000 shares of LXEO for $40,496 on Oct 10 ’24. The Chief Executive Officer now owns 120,695 shares after completing the transaction at $8.10 per share. On Sep 10 ’24, another insider, Townsend Richard Nolan, who serves as the Chief Executive Officer of the company, sold 5,000 shares for $10.65 each. As a result, the insider received 53,274 and left with 120,695 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXEO now has a Market Capitalization of 219888240 and an Enterprise Value of 90110120.
Stock Price History:
Over the past 52 weeks, LXEO has reached a high of $22.33, while it has fallen to a 52-week low of $7.47. The 50-Day Moving Average of the stock is -26.17%, while the 200-Day Moving Average is calculated to be -48.40%.
Shares Statistics:
It appears that LXEO traded 389.27K shares on average per day over the past three months and 913940 shares per day over the past ten days. A total of 26.65M shares are outstanding, with a floating share count of 21.71M. Insiders hold about 32.52% of the company’s shares, while institutions hold 73.89% stake in the company. Shares short for LXEO as of 1730332800 were 2193871 with a Short Ratio of 5.64, compared to 1727654400 on 2073094. Therefore, it implies a Short% of Shares Outstanding of 2193871 and a Short% of Float of 7.4200004.
